Stay updated with breaking news from Rupak Pathak. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The study will focus on the relationship between chronic kidney disease, or CKD, and platelets, the small, colorless fragments in blood that form clots and stop or prevent bleeding.
The U.S. announced the purchase of nearly $300 million worth of the drug last week—here's how it works.
The five-year study aims to encourage drug development for therapies that will reduce the effects of such injuries.